An enlarged prostate, called Benign Prostatic Hyperplasia (BPH), can narrow or even block the urethra, causing bothersome urinary symptoms. In fact, BPH affects more than 500 million men worldwide. Traditional treatments such as surgery and pills can entail negative complications and side effects, causing many men to avoid treatment and live with the debilitating problem.
A minimally invasive solution
Tegra Medical produces the core components of an early treatment option for BPH. This treatment is the only leading procedure that does not require heating, cutting, removal, or destruction of prostate tissue – delivering rapid symptom relief and recovery. Performed in a doctor’s office, the minimally invasive procedure inserts tiny implants that hold the enlarged prostate tissue out of the way, so it no longer blocks the urethra.
Expertise in metal
The complex needle Tegra Medical produces deploys the implant and sutures. It is a good example of our expertise in nitinol shape setting. Nitinol can be formed into complex shapes to easily reach a body part. In the case of the prostate device, the needle is manufactured with the exact curve needed to access the prostate, without damaging surrounding tissue.